Sernova Welcomes Dr. Bernd Muehlenweg as Evotec's Nominee for Its Board of Directors
Yahoo FinanceApr 22 07:00 ET
Express News | Raymond James Initiates Coverage On Sernova With Market Perform Rating, Announces Price Target of $1.5
Moomoo 24/7Apr 4 13:49 ET
Sernova Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/04/2024 277.41% Raymond James → $1.5 Initiates Coverage On → Market Perform
BenzingaApr 4 13:47 ET
Sernova Reports Anticipated 2024 Milestones
Seeking AlphaJan 29 07:21 ET
Sernova Gets FDA Orphan Drug, Rare Pediatric Designations for Hemophilia A
Seeking AlphaNov 27, 2023 15:06 ET
Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for Its Hemophilia A Program From FDA
LONDON, Ontario and WINDHAM COUNTY, Conn., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced the U.S.
GlobeNewswireNov 27, 2023 07:19 ET
Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress
All six patients in the first cohort (Cohort A) were successfully implanted with the 8-channel Cell Pouch System with post-transplant follow-up periods ranging from 6 months to 3.5 years;5 of 6 patients in Cohort A
GlobeNewswireOct 27, 2023 07:00 ET
Sernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA Congress
Dr. Piotr Witkowski presenting new data from ongoing Phase 1/2 clinical trial of the Cell Pouch System in patients with type 1 diabetes (T1D) Dr. Alice Tomei presenting preclinical data on transplantation of
GlobeNewswireOct 11, 2023 07:00 ET
Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22
LONDON, Ontario and WINDHAM COUNTY, Conn., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced it has
GlobeNewswireSep 14, 2023 16:05 ET
Slone Partners Places Cynthia Pussinen as Chief Executive Officer and Member of the Board of Directors at Sernova Corporation
Industry veteran will lead the company's next stage of growth and development SOUTH RIDING, Va., Sept. 14, 2023 /PRNewswire-PRWeb/ -- Slone Partners, a nationwide executive search firm for life sciences, healthcare,
PR NewswireSep 14, 2023 04:00 ET
Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update
- Introduction of New CEO Cynthia Pussinen and Recently Appointed Chief Business Officer, Dr. Modestus Obochi, on September 15, 2023 - - Business Update, Strategy & Outlook Call on October 5, 2023 - LONDON,
GlobeNewswireSep 13, 2023 07:00 ET
Sernova Provides Development Update on Proprietary Cellular Conformal Coating Technology in Combination With Cell Pouch Device
LONDON, Ontario and WINDHAM COUNTY, Conn., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today provided a
GlobeNewswireSep 7, 2023 07:00 ET
Sernova Appoints CEO
Seeking AlphaSep 5, 2023 07:29 ET
Sernova Corporation Announces the Appointment of Cynthia Pussinen as CEO
Stockhouse Sep 5, 2023 07:00 ET
Sernova Announces Positive Updated Interim Phase 1/2 Clinical Data for the Cell Pouch System at American Diabetes Association 83rd Scientific Sessions
In the first cohort of the ongoing Phase 1/2 clinical trial, the first 5 patients to complete protocol-defined islet transplants achieved insulin-independence for ongoing periods of 6 to 38 months.Following islet
GlobeNewswireJun 26, 2023 07:50 ET
Sernova to Present Updated Interim Phase 1/2 Clinical Data on Cell Pouch System During Oral Presentation at American Diabetes Association 83rd Scientific Sessions
Company to host in-person only analyst and investor event at an offsite location following the presentation on Saturday, June 24 at the ADA Scientific SessionsLONDON, Ontario, June 22, 2023 (GLOBE N
GlobeNewswireJun 22, 2023 17:16 ET
Sernova to Participate in Upcoming Truist Securities Cell Therapy Symposium
LONDON, Ontario, June 16, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced it will be partici
GlobeNewswireJun 16, 2023 11:28 ET
Sernova Announces Executive Alignment and Appoints New Board Chair
LONDON, Ontario, May 31, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a clinical-stage company and leader in cell therapeutics, today announced the outcomes fro
GlobeNewswireMay 31, 2023 07:00 ET
Sernova Shares Jump With AstraZeneca Collaboration
Sernova's shares rallied Wednesday after the biotechnology company entered a preclinical research collaboration with AstraZeneca to evaluate the use of its Cell Pouch System in combination with AstraZeneca's novel therapeutic cells.
Dow JonesMay 3, 2023 11:05 ET
Sernova Has Entered Into A Preclinical Research Collaboration With AstraZeneca To Evaluate The Use Of Sernova's Cell Pouch System In Combination With AstraZeneca's Novel Therapeutic Cells, Deal Terms Were Not Disclosed
Under the terms of the collaboration, AstraZeneca will lead and completely fund the development of the cell technologies and pre-clinical activities in conjunction with Sernova. The discovery work is
BenzingaMay 3, 2023 07:31 ET
No Data
No Data